We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,653.00
Bid: 1,654.00
Ask: 1,654.50
Change: 12.50 (0.76%)
Spread: 0.50 (0.03%)
Open: 1,638.50
High: 1,655.50
Low: 1,634.00
Prev. Close: 1,640.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FTSE 100 movers: easyJet leaps on CEO interview

Tue, 10th Sep 2013 14:39

easyJet shares are firmly on the rise, extending yesterday's gain of around one per cent. The company has said it's geared up to take on other low-cost airlines across Europe, saying it expects other airlines will have difficulty in embracing a no-frills style. It said the loss of as many as 86m short-haul passengers could be easyJet's gain. Speaking to Bloomberg, Chief Executive Officer Carolyn McCall said "I don't see why any legacy carrier would want to continue losing money on short-haul when it can be done better by other carriers, except to feed their long-haul."Yesterday's rise came after Bank of America Merrill Lynch predicted that October's fourth-quarter trading update would see a continuation of its robust yield performance, and suggested a special dividend could also be on the cards. Monday also saw the company add two new routes, with seats to go on sale from next month. Sector peer IAG was also a strong riser, as crude continued to pull back from its recent highs as fears over turmoil in the Middle East ease. Elevated oil prices have pressured both stocks over the last few weeks on concerns over the knock-on effects to jet fuel costs. Financials were also performing well today with RBS, Standard Chartered, Aviva, Aberdeen Asset Management and Schroders among the highest risers.Leading the downside was Costa and Premier Inn owner Whitbread after seeing sales growth slow from 13.8% in the first quarter to just 10.8% in the second as the hot summer weather hit demand at its coffee shops.Pharma giant GlaxoSmithKline also fell sharply after US regulators set out requirements for generic versions of its lung drug Advair, sparking competition concerns over when patents run out in a few years' time.Miners were putting in a mixed performance as increased risk appetite was offset by falling metals prices across the board. Glencore Xstrata was in demand after lifting its synergy target - following its merger - to at least $2bn next year as the miner vowed to cut costs and improve operational efficiency. Precious metals groups Fresnillo and Randgold, however, were out of favour. Rolls-Royce gained after scoring a $175m contract with Asia Gas Pipeline (AGP) for services on a natural gas pipeline in Kazakhstan.FTSE 100 - RiserseasyJet (EZJ) 1,355.00p +6.95%International Consolidated Airlines Group SA (CDI) (IAG) 319.90p +4.71%Aberdeen Asset Management (ADN) 385.20p +4.33%Royal Bank of Scotland Group (RBS) 353.50p +3.97%Standard Chartered (STAN) 1,510.00p +3.74%Prudential (PRU) 1,173.00p +3.17%Aviva (AV.) 412.00p +3.05%Glencore Xstrata (GLEN) 330.75p +2.94%Babcock International Group (BAB) 1,189.00p +2.85%Legal & General Group (LGEN) 199.20p +2.79%FTSE 100 - FallersWhitbread (WTB) 3,123.00p -2.89%GlaxoSmithKline (GSK) 1,595.50p -2.71%Fresnillo (FRES) 1,238.00p -2.44%Randgold Resources Ltd. (RRS) 4,803.00p -2.26%Eurasian Natural Resources Corp. (ENRC) 222.00p -1.25%Vodafone Group (VOD) 208.90p -0.71%BG Group (BG.) 1,210.00p -0.58%Vedanta Resources (VED) 1,189.00p -0.08%Centrica (CNA) 395.60p -0.05%NR
More News
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more
22 Nov 2023 09:48

LONDON BROKER RATINGS: RBC cuts HSBC; Liberum cuts Glencore

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.